Genetically Proxied CRP (C-Reactive Protein) Levels and Lobar Intracerebral Hemorrhage Risk

Author:

Myserlis Evangelos Pavlos1ORCID,Anderson Christopher D.2345ORCID,Georgakis Marios K.2346ORCID

Affiliation:

1. Department of Neurology, Medical University of South Carolina, Charleston (E.P.M.).

2. Center for Genomic Medicine (C.D.A., M.K.G.), Massachusetts General Hospital, Boston.

3. Henry and Alisson McCance Center for Brain Health (C.D.A., M.K.G.), Massachusetts General Hospital, Boston.

4. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA (C.D.A., M.K.G.).

5. Department of Neurology, Brigham and Women’s Hospital, Boston, MA (C.D.A.).

6. Institute for Stroke and Dementia Research (ISD), LMU University Hospital, Ludwig-Maximillians-University, Munich, Germany (M.K.G.).

Abstract

Background: Recent evidence suggests that higher CRP (C-reactive protein) levels are associated with lower risk of Alzheimer disease, speculating that CRP might be involved in Aβ clearance mechanisms. Testing this hypothesis, we explored whether genetically proxied CRP levels are also associated with lobar intracerebral hemorrhage (ICH), commonly caused by cerebral amyloid angiopathy. Methods: We used 4 genetic variants within the CRP gene that explain up to 64% of the variance of circulating CRP levels and explored in 2-sample Mendelian randomization analyses associations with risk of any, lobar, and deep ICH (1545 cases and 1481 controls). Results: Higher genetically proxied CRP levels were associated with lower odds of lobar ICH (odds ratio per SD increment in CRP, 0.45 [95% CI, 0.25–0.73]) but not deep ICH (odds ratio, 0.72 [95% CI, 0.45–1.14]). There was evidence of colocalization (posterior probability of association, 72.4%) in the signals for CRP and lobar ICH. Conclusions: Our results provide supportive evidence that high CRP levels may have a protective role in amyloid-related pathology.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3